Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolution of lipoprotein patterns in newborns

J P Van Biervliet, R Vercaemst, W De Keersgieter

    Acta Paediatrica Scandinavica
    |September 1, 1980
    PubMed
    Summary

    Newborn lipid profiles, including cholesterol and apolipoproteins, change significantly in the first week of life. Measuring these markers at 7 days offers a better screening for congenital hypercholesterolemia than cord blood.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nutritional intake evolution in adolescent sporting boys over the last two decades.

    Acta clinica Belgica·2011
    Same author

    The effect of zinc supplements in cystic fibrosis patients.

    Annals of nutrition & metabolism·2008
    Same author

    Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients.

    Prostaglandins, leukotrienes, and essential fatty acids·2008
    Same author

    Serum zinc concentrations in cystic fibrosis patients aged above 4 years: a cross-sectional evaluation.

    Biological trace element research·2007
    Same author

    An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.

    American journal of human genetics·2006
    Same author

    Docosahexaenoic acid trials in cystic fibrosis: a review of the rationale behind the clinical trials.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2005

    Area of Science:

    • Neonatal physiology
    • Lipid metabolism
    • Cardiovascular health

    Background:

    • Infant lipid profiles are crucial for early detection of metabolic disorders.
    • Understanding early lipoprotein evolution informs long-term cardiovascular risk assessment.
    • Congenital hypercholesterolemia screening requires reliable early indicators.

    Purpose of the Study:

    • To track the changes in plasma lipids and apolipoproteins in newborns during the first month of life.
    • To determine the optimal time point for screening neonatal lipid disorders.
    • To evaluate the utility of specific lipid ratios as predictors of atherosclerosis.

    Main Methods:

    • Plasma levels of total cholesterol, HDL cholesterol, apo B, and apo A-I were measured in 30 newborns.

    Related Experiment Videos

  • Samples were collected at birth (cord blood), 7 days, and 30 days of life.
  • Cholesterol/apoprotein ratios (LDL and HDL) were analyzed.

    • Main Results:

    • Newborns exhibit low LDL cholesterol and apo B at birth, with rapid increases by day 7.
    • HDL cholesterol and apo A-I levels are high at birth and increase gradually.
    • Cholesterol/apoprotein ratios remained stable within LDL and HDL classes throughout the study period.

    Conclusions:

    • Plasma lipid and apoprotein levels at 7 days are more indicative of neonatal metabolic status than cord blood levels.
    • Screening for congenital hypercholesterolemia may be more effective at 7 days of life.
    • Cholesterol/apo B and apo B/apo A-I ratios are valuable screening parameters for predicting atherosclerosis risk.